Cowen and Company’s Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share HIPO.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding HIPO.WS
Cowen and Company's HIPO.WS Position: Q3 2024 in Review
Cowen and Company sold out of Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share (HIPO.WS) in Q3 2024, closing a stake of 525,630 shares — an estimated $8.52K sold.
Cowen and Company first reported a position in HIPO.WS in Q3 2021 and held it in 12 quarters. The position peaked at $66K in Q2 2022. 2 funds tracked by Wall St. Rank hold HIPO.WS as of Q3 2024.
- Cowen and Company reported no remaining Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position as of Q3 2024 after selling out during the quarter.
- Cowen and Company sold 525,630 Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share shares in Q3 2024, an estimated $8.52K.
- Cowen and Company first reported a position in Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share in Q3 2021 and held it in 12 quarters.
- Cowen and Company's Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share position peaked at $66K in Q2 2022.
- 2 funds tracked by Wall St. Rank held Hippo Holdings Inc. Redeemable warrants, each whole warrant exercisable for one twenty-fifth (1/25) share of Common Stock at an exercise price of $287.50 per full share as of Q3 2024.
Based on Cowen and Company's 13F filing for Q3 2024, filed 12 Nov 2024.